$OBLN #Obalon Therapeutics ... InsiderInsights Weekly Tables: August 10, 2019
| InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and...
View Article$OBLN #Obalon Therapeutics Obalon Engages Helmuth T. Billy, MD as Medical...
Obalon Engages Helmuth T. Billy, MD as Medical Director for its First Company-Owned Weight Loss Treatment Center Leading bariatric surgeon and authority in the field to oversee medical activities for...
View Article$OBLN #Obalon Therapeutics Obalon Announces Repayment of All Long-Term Debt...
| Obalon Announces Repayment of All Long-Term Debt and Regaining of Compliance with NASDAQ Listing Requirement SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:), a San...
View Article$OBLN #Obalon Therapeutics Obalon Announces First Patient Treatments at its...
Obalon Announces First Patient Treatments at its First Company-Owned Center for Weight Loss SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:), a weight loss solutions...
View Article$OBLN #Obalon Therapeutics Obalon Appoints William J. Plovanic as Chief...
Obalon Appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer Solidified leadership and strengthened financial position in place to leverage the...
View Article$OBLN #Obalon Therapeutics Obalon Schedules Third Quarter 2019 Financial...
Obalon Schedules Third Quarter 2019 Financial Results Conference Call for November 8, 2019 at 9:00 a.m. Eastern Time SAN DIEGO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:...
View Article$OBLN #Obalon Therapeutics Obalon Announces Clinical Data Set to be Featured...
Obalon Announces Clinical Data Set to be Featured During the 36th ASMBS Annual Meeting at Obesity Week 2019 Real-world results from 222 consecutive patients treated with the Obalon Balloon System...
View Article$OBLN #Obalon Therapeutics Obalon Announces Third Quarter 2019 Financial Results
| Obalon Announces Third Quarter 2019 Financial Results SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weight loss solutions company with the first and only...
View Article$OBLN #Obalon Therapeutics Obalon To Present at Two Upcoming Institutional...
Obalon To Present at Two Upcoming Institutional Investor Conferences SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: ), a weight loss solutions company focused on...
View Article$OBLN #Obalon Therapeutics Obalon Enters into a Distribution Agreement for Qatar
Obalon Enters into a Distribution Agreement for Qatar SAN DIEGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:), a vertically integrated weight loss solutions company with the...
View Article$OBLN #Obalon Therapeutics Obalon Enters into New Stock Purchase Agreement...
Obalon Enters into New Stock Purchase Agreement with Lincoln Park Capital Fund SAN DIEGO, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:), a vertically integrated weight loss...
View Article$OBLN #Obalon Therapeutics Obalon Schedules Fourth Quarter and Year-End 2019...
Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time SAN DIEGO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics,...
View Article$OBLN #Obalon Therapeutics Obalon Announces Opening of Second Retail...
Obalon Announces Opening of Second Retail Treatment Center in Orange County, CA Company continues to execute on its strategy to develop retail treatment sites focused exclusively on treatment with the...
View Article$OBLN #Obalon Therapeutics Obalon Announces Fourth Quarter and Full Year 2019...
Obalon Announces Fourth Quarter and Full Year 2019 Financial Results SAN DIEGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology...
View Article$OBLN #Obalon Therapeutics Obalon Temporarily Suspends New Patient Sales at...
Obalon Temporarily Suspends New Patient Sales at Its Retail Treatment Centers Due to Coronavirus Pandemic No patients or employees have been found to be symptomatic or positive for the virus, yet...
View Article$OBLN #Obalon Therapeutics Obalon Engages Canaccord Genuity to Explore...
Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:), a vertically integrated weight loss...
View Article$OBLN #Obalon Therapeutics Obalon Gas-Filled Balloon Not Subject of Fourth...
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons Obalon reported no...
View Article$OBLN #Obalon Therapeutics William Plovanic Resigns as President and Chief...
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director Obalon’s Executive Chairman, Andy Rasdal, will reassume CEO position SAN DIEGO, May 08,...
View Article$OBLN #Obalon Therapeutics Obalon Announces Further Impacts Related To...
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”)...
View Article$OBLN #Obalon Therapeutics Obalon Announces First Quarter 2020 Financial...
Obalon Announces First Quarter 2020 Financial Results and Business Update SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with...
View Article
